alluvi541578 - Profile

About me

Profile

Alluvi, previously BI 4744, presents a notable breakthrough in obesity care. This dual agonist targeting both glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide sites

https://alluvi-research.co.uk/